Andrea P. Moy

1.3k total citations · 1 hit paper
45 papers, 823 citations indexed

About

Andrea P. Moy is a scholar working on Oncology, Dermatology and Immunology. According to data from OpenAlex, Andrea P. Moy has authored 45 papers receiving a total of 823 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 16 papers in Dermatology and 13 papers in Immunology. Recurrent topics in Andrea P. Moy's work include Cutaneous Melanoma Detection and Management (9 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Chemotherapy-related skin toxicity (5 papers). Andrea P. Moy is often cited by papers focused on Cutaneous Melanoma Detection and Management (9 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Chemotherapy-related skin toxicity (5 papers). Andrea P. Moy collaborates with scholars based in United States, Austria and India. Andrea P. Moy's co-authors include Mario E. Lacouture, Donald Y.M. Leung, Jeffrey A. Kern, Dulce M. Barrios, Gregory S. Phillips, Amaris Geisler, Jennifer Wu, Rosalynn M. Nazarian, Mandakolathur R. Murali and Klaus J. Busam and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Andrea P. Moy

41 papers receiving 816 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immune checkpoint inhibitor–related dermatologic adverse events

2020 298 citations Amaris Geisler, Gregory S. Phillips et al. Journal of the American Academy of Dermatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrea P. Moy United States	14	435	267	219	196	130	45	823
É. Frouin France	14	227 0.5×	288 1.1×	155 0.7×	97 0.5×	130 1.0×	52	670
Nicolas Poulalhon France	17	398 0.9×	366 1.4×	207 0.9×	129 0.7×	323 2.5×	33	1.0k
Chris J.L.M. Meijer Netherlands	10	283 0.7×	402 1.5×	328 1.5×	178 0.9×	77 0.6×	10	869
Kamel Laribi France	17	606 1.4×	140 0.5×	329 1.5×	149 0.8×	336 2.6×	62	1.2k
Hiroo Hata Japan	17	452 1.0×	226 0.8×	87 0.4×	212 1.1×	185 1.4×	62	875
Julia Valencak Austria	18	475 1.1×	169 0.6×	332 1.5×	73 0.4×	133 1.0×	38	939
Daniela Stramazzotti Italy	16	268 0.6×	70 0.3×	81 0.4×	203 1.0×	197 1.5×	43	894
Jooryung Huh South Korea	20	627 1.4×	102 0.4×	772 3.5×	271 1.4×	138 1.1×	54	1.2k
Inny Busmanis Singapore	15	185 0.4×	201 0.8×	278 1.3×	34 0.2×	130 1.0×	46	836
Soo Kee Min South Korea	16	309 0.7×	65 0.2×	170 0.8×	103 0.5×	219 1.7×	58	744

Countries citing papers authored by Andrea P. Moy

Since Specialization

Citations

This map shows the geographic impact of Andrea P. Moy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea P. Moy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea P. Moy more than expected).

Fields of papers citing papers by Andrea P. Moy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea P. Moy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea P. Moy. The network helps show where Andrea P. Moy may publish in the future.

Co-authorship network of co-authors of Andrea P. Moy

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea P. Moy. A scholar is included among the top collaborators of Andrea P. Moy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea P. Moy. Andrea P. Moy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Reingold, Rachel, Guilherme Harada, Andrea P. Moy, et al.. (2025). Mucocutaneous Adverse Events in Patients With Cancer Treated with the Highly Selective RET Kinase Inhibitor Selpercatinib (LOXO-292). JTO Clinical and Research Reports. 6(3). 100792–100792. 1 indexed citations

Moy, Andrea P., Stephen W. Dusza, Alison J. Moskowitz, et al.. (2025). Dupilumab for bullous pemphigoid related to immune checkpoint inhibitors: a retrospective case series. The Oncologist. 30(9). 2 indexed citations

Smithy, James W., Andrea P. Moy, Colleen Maher, et al.. (2025). Quantitatively defined stromal B cell aggregates are associated with response to checkpoint inhibitors in unresectable melanoma. Cell Reports. 44(4). 115554–115554. 1 indexed citations

Geller, Shamir, et al.. (2025). CCR8 Immunohistochemistry Highlights CCR8 as a Diagnostic and Therapeutic Biomarker in Cutaneous T-Cell Lymphoma. Journal of Investigative Dermatology. 145(12). 3231–3233.e2. 1 indexed citations

Kurtansky, Nicholas R., Emily R. Nadelmann, Andrea P. Moy, et al.. (2024). Declining Clinical Utility of Tools for Predicting Sentinel Lymph Node Biopsy Status: A Single Institution Experience from 2000 to 2021. Annals of Surgical Oncology. 32(3). 1463–1472. 2 indexed citations

Lacouture, Mario E., Elena Goleva, Neil J. Shah, et al.. (2024). Immunologic Profiling of Immune-Related Cutaneous Adverse Events with Checkpoint Inhibitors Reveals Polarized Actionable Pathways. Clinical Cancer Research. 30(13). 2822–2834. 13 indexed citations

Busam, Klaus J., Cecilia Lezcano, Andrea P. Moy, et al.. (2024). Superficial Wnt-Activated Melanocytic Nevi/Melanocytomas With a Junctional Component: A Case Series. American Journal of Dermatopathology. 46(10). 648–652. 1 indexed citations

Goleva, Elena, Mario E. Lacouture, Taras Lyubchenko, et al.. (2024). Checkpoint inhibitor-related skin reactions in cancer patients are characterized by unique rash specific immune responses. Journal of Allergy and Clinical Immunology. 153(2). AB227–AB227.

Moy, Andrea P., Stephen W. Dusza, Yelena Y. Janjigian, et al.. (2023). Management of immune-related cutaneous adverse events with dupilumab. Journal for ImmunoTherapy of Cancer. 11(6). e007324–e007324. 25 indexed citations

10.

Moy, Andrea P., et al.. (2023). IL12/23 Blockade with Ustekinumab as a Treatment for Immune-Related Cutaneous Adverse Events. Pharmaceuticals. 16(11). 1548–1548. 6 indexed citations

11.

Dusza, Stephen W., Elizabeth Quigley, Alina Markova, et al.. (2023). Pruritus related to trastuzumab and pertuzumab in HER2 + breast cancer patients. Breast Cancer Research and Treatment. 203(2). 271–280. 2 indexed citations

12.

Barrios, Dulce M., Melissa Pulitzer, Andrea P. Moy, et al.. (2023). Acute Febrile Neutrophilic Dermatosis (Sweet Syndrome) in Acute Myeloid Leukemia Patients: A 28-Year Institutional Experience. Acta Haematologica. 147(4). 457–464. 2 indexed citations

13.

Nocco, Sarah E., Mark D. Ewalt, Andrea P. Moy, et al.. (2023). TRBC1 immunohistochemistry distinguishes cutaneous T-cell lymphoma from inflammatory dermatitis: A retrospective analysis of 39 cases. Journal of the American Academy of Dermatology. 90(4). 839–841. 4 indexed citations

14.

Smithy, James W., Yanyun Li, Andrea P. Moy, et al.. (2023). 1303 Spatial topic modeling of tumor microenvironment with multiplexed imaging. SHILAP Revista de lepidopterología. A1448–A1448. 1 indexed citations

15.

Costa, Bruno Almeida, Victor Zibara, Vasundhara Singh, et al.. (2022). Case report: Later onset of NRAS-mutant metastatic melanoma in a patient with a partially-excised giant congenital melanocytic nevus. Frontiers in Medicine. 9. 1086473–1086473.

16.

Vanderbilt, Chad, Thomas Brenn, Andrea P. Moy, et al.. (2022). Association of HPV42 with digital papillary adenocarcinoma and the use of in situ hybridization for its distinction from acral hidradenoma and diagnosis at non-acral sites. Modern Pathology. 35(10). 1405–1410. 20 indexed citations

17.

Geisler, Amaris, Gregory S. Phillips, Dulce M. Barrios, et al.. (2020). Immune checkpoint inhibitor–related dermatologic adverse events. Journal of the American Academy of Dermatology. 83(5). 1255–1268. 298 indexed citations breakdown →

18.

Williams, Erik A., Andrea P. Moy, Nicole A. Cipriani, Sagar U. Nigwekar, & Rosalynn M. Nazarian. (2018). Factors associated with false‐negative pathologic diagnosis of calciphylaxis. Journal of Cutaneous Pathology. 46(1). 16–25. 15 indexed citations

19.

Zhou, Xiaolong, Abner Louissaint, Alexander T. Wenzel, et al.. (2018). Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell Lymphoma, Leg Type. Journal of Investigative Dermatology. 138(11). 2365–2376. 51 indexed citations

20.

Moy, Andrea P., Mark C. Mochel, Alona Muzikansky, Lyn M. Duncan, & Stefan Kraft. (2017). Lymphatic invasion predicts sentinel lymph node metastasis and adverse outcome in primary cutaneous melanoma. Journal of Cutaneous Pathology. 44(9). 734–739. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact